Table 1.

Demographic and clinical characteristics of the patients. (Data are expressed as n (%) or mean ± SD.)

		ALP + BC	ALP	BC	F	P
Sex	Male	48 (65.75)	49 (69.01)	56 (32.15)	0.174	0.677
	Female	25 (34.25)	22 (30.99)	31 (41.65)
Age, y		58 ± 10.05	56.13 ± 14.28	57.95 ± 11.98	0.565	0.569
Serum glucose, mmol/L		5.8 ± 2.11	5.47 ± 1.28	5.48 ± 1.66	0.909	0.404
TG, mmol/L		1.72 ± 0.98	1.93 ± 1.41	1.86 ± 1.57	0.467	0.627
TC, mmol/L		4.53 ± 1.23	4.42 ± 1.25	4.58 ± 1.43	0.320	0.726
HDL-C, mmol/L		1.1 ± 0.22	1.14 ± 0.22	1.47 ± 2.16	1.849	0.160
LDL-C, mmol/L		2.84 ± 0.97	2.89 ± 0.88	2.75 ± 0.92	0.450	0.638
Serum uric acid, µmol/L		305.17 ± 86.15	315.3 ± 80.42	306.98 ± 86.05	0.298	0.742
Homocysteine, µmol/L		15.03 ± 6.7	14.24 ± 5.99	13.84 ± 6.18	0.720	0.488

ALP, alprazolam; BC, Bailemian capsule; TG, triglyceride; TC, cholesterol; HDL-C; LDL-C.